Acetylation of the pro-apoptotic factor, p53 in the hippocampus following cerebral ischemia and modulation by estrogen.

<h4>Background</h4>Recent studies demonstrate that acetylation of the transcription factor, p53 on lysine(373) leads to its enhanced stabilization/activity and increased susceptibility of cells to stress. However, it is not known whether acetylation of p53 is altered in the hippocampus f...

Full description

Saved in:
Bibliographic Details
Main Authors: Limor Raz, Quan-guang Zhang, Dong Han, Yan Dong, Liesl De Sevilla, Darrell W Brann
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2011-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0027039&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849727692230885376
author Limor Raz
Quan-guang Zhang
Dong Han
Yan Dong
Liesl De Sevilla
Darrell W Brann
author_facet Limor Raz
Quan-guang Zhang
Dong Han
Yan Dong
Liesl De Sevilla
Darrell W Brann
author_sort Limor Raz
collection DOAJ
description <h4>Background</h4>Recent studies demonstrate that acetylation of the transcription factor, p53 on lysine(373) leads to its enhanced stabilization/activity and increased susceptibility of cells to stress. However, it is not known whether acetylation of p53 is altered in the hippocampus following global cerebral ischemia (GCI) or is regulated by the hormone, 17β-estradiol (17β-E(2)), and thus, this study examined these issues.<h4>Methodology/principal findings</h4>The study revealed that Acetyl p53-Lysine(373) levels were markedly increased in the hippocampal CA1 region after GCI at 3 h, 6 h and 24 h after reperfusion, an effect strongly attenuated by 17β-E(2). 17β-E(2) also enhanced interaction of p53 with the ubiquitin ligase, Mdm2, increased ubiquitination of p53, and induced its down-regulation, as well as attenuated elevation of the p53 transcriptional target, Puma. We also observed enhanced acetylation of p53 at a different lysine (Lys(382)) at 3 h after reperfusion, and 17β-E(2) also markedly attenuated this effect. Furthermore, administration of an inhibitor of CBP/p300 acetyltransferase, which acetylates p53, was strongly neuroprotective of the CA1 region following GCI. In long-term estrogen deprived (LTED) animals, the ability of 17β-E(2) to attenuate p53 acetylation was lost, and intriguingly, Acetyl p53-Lysine(373) levels were markedly elevated in sham (non-ischemic) LTED animals. Finally, intracerebroventricular injections of Gp91ds-Tat, a specific NADPH oxidase (NOX2) inhibitor, but not the scrambled tat peptide control (Sc-Tat), attenuated acetylation of p53 and reduced levels of Puma following GCI.<h4>Conclusions/significance</h4>The studies demonstrate that p53 undergoes enhanced acetylation in the hippocampal CA1 region following global cerebral ischemia, and that the neuroprotective agent, 17β-E(2), markedly attenuates the ischemia-induced p53 acetylation. Furthermore, following LTED, the suppressive effect of 17β-E(2) on p53 acetylation is lost, and p53 acetylation increases in the hippocampus, which may explain previous reports of increased sensitivity of the hippocampus to ischemic stress following LTED.
format Article
id doaj-art-6bc637a5cf8b4fbd9aa3567f81e68dba
institution DOAJ
issn 1932-6203
language English
publishDate 2011-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-6bc637a5cf8b4fbd9aa3567f81e68dba2025-08-20T03:09:47ZengPublic Library of Science (PLoS)PLoS ONE1932-62032011-01-01610e2703910.1371/journal.pone.0027039Acetylation of the pro-apoptotic factor, p53 in the hippocampus following cerebral ischemia and modulation by estrogen.Limor RazQuan-guang ZhangDong HanYan DongLiesl De SevillaDarrell W Brann<h4>Background</h4>Recent studies demonstrate that acetylation of the transcription factor, p53 on lysine(373) leads to its enhanced stabilization/activity and increased susceptibility of cells to stress. However, it is not known whether acetylation of p53 is altered in the hippocampus following global cerebral ischemia (GCI) or is regulated by the hormone, 17β-estradiol (17β-E(2)), and thus, this study examined these issues.<h4>Methodology/principal findings</h4>The study revealed that Acetyl p53-Lysine(373) levels were markedly increased in the hippocampal CA1 region after GCI at 3 h, 6 h and 24 h after reperfusion, an effect strongly attenuated by 17β-E(2). 17β-E(2) also enhanced interaction of p53 with the ubiquitin ligase, Mdm2, increased ubiquitination of p53, and induced its down-regulation, as well as attenuated elevation of the p53 transcriptional target, Puma. We also observed enhanced acetylation of p53 at a different lysine (Lys(382)) at 3 h after reperfusion, and 17β-E(2) also markedly attenuated this effect. Furthermore, administration of an inhibitor of CBP/p300 acetyltransferase, which acetylates p53, was strongly neuroprotective of the CA1 region following GCI. In long-term estrogen deprived (LTED) animals, the ability of 17β-E(2) to attenuate p53 acetylation was lost, and intriguingly, Acetyl p53-Lysine(373) levels were markedly elevated in sham (non-ischemic) LTED animals. Finally, intracerebroventricular injections of Gp91ds-Tat, a specific NADPH oxidase (NOX2) inhibitor, but not the scrambled tat peptide control (Sc-Tat), attenuated acetylation of p53 and reduced levels of Puma following GCI.<h4>Conclusions/significance</h4>The studies demonstrate that p53 undergoes enhanced acetylation in the hippocampal CA1 region following global cerebral ischemia, and that the neuroprotective agent, 17β-E(2), markedly attenuates the ischemia-induced p53 acetylation. Furthermore, following LTED, the suppressive effect of 17β-E(2) on p53 acetylation is lost, and p53 acetylation increases in the hippocampus, which may explain previous reports of increased sensitivity of the hippocampus to ischemic stress following LTED.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0027039&type=printable
spellingShingle Limor Raz
Quan-guang Zhang
Dong Han
Yan Dong
Liesl De Sevilla
Darrell W Brann
Acetylation of the pro-apoptotic factor, p53 in the hippocampus following cerebral ischemia and modulation by estrogen.
PLoS ONE
title Acetylation of the pro-apoptotic factor, p53 in the hippocampus following cerebral ischemia and modulation by estrogen.
title_full Acetylation of the pro-apoptotic factor, p53 in the hippocampus following cerebral ischemia and modulation by estrogen.
title_fullStr Acetylation of the pro-apoptotic factor, p53 in the hippocampus following cerebral ischemia and modulation by estrogen.
title_full_unstemmed Acetylation of the pro-apoptotic factor, p53 in the hippocampus following cerebral ischemia and modulation by estrogen.
title_short Acetylation of the pro-apoptotic factor, p53 in the hippocampus following cerebral ischemia and modulation by estrogen.
title_sort acetylation of the pro apoptotic factor p53 in the hippocampus following cerebral ischemia and modulation by estrogen
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0027039&type=printable
work_keys_str_mv AT limorraz acetylationoftheproapoptoticfactorp53inthehippocampusfollowingcerebralischemiaandmodulationbyestrogen
AT quanguangzhang acetylationoftheproapoptoticfactorp53inthehippocampusfollowingcerebralischemiaandmodulationbyestrogen
AT donghan acetylationoftheproapoptoticfactorp53inthehippocampusfollowingcerebralischemiaandmodulationbyestrogen
AT yandong acetylationoftheproapoptoticfactorp53inthehippocampusfollowingcerebralischemiaandmodulationbyestrogen
AT liesldesevilla acetylationoftheproapoptoticfactorp53inthehippocampusfollowingcerebralischemiaandmodulationbyestrogen
AT darrellwbrann acetylationoftheproapoptoticfactorp53inthehippocampusfollowingcerebralischemiaandmodulationbyestrogen